Ervebo

Ervebo is a vaccine designed to prevent Ebola virus disease caused by Zaire ebolavirus. It uses a recombinant vesicular stomatitis virus to trigger an immune response. This vaccine is administered intramuscularly and is manufactured by Merck Sharp & Dohme B.V.

Ervebo is used to protect against Ebola virus disease, specifically the Zaire ebolavirus strain. This vaccine is intended for individuals at risk of exposure to the virus, such as healthcare workers and those in outbreak areas. It works by stimulating the immune system to produce antibodies against the Ebola virus.

Common effects of Ervebo may include soreness at the injection site, headache, fatigue, and muscle pain. These effects are generally mild and temporary. As with any vaccine, individuals may experience different reactions, and it is important to monitor for any unusual symptoms.

Ervebo should be administered by healthcare professionals trained in vaccination procedures. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with weakened immune systems should consult their healthcare provider before vaccination.

Ervebo may interact with other medications or vaccines. It is important to discuss all current medications with your healthcare provider before receiving the vaccine. Additionally, individuals should avoid taking immunosuppressant drugs around the time of vaccination, as these can reduce the vaccine's effectiveness.